Pseudomonas aeruginosa: resistance to the max

Cited by papers we hold 14

• Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies · 2024
  No notice
• Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability · 2024
  No notice
• Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance · 2022
  No notice
• It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa · 2021
  No notice
• The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies · 2021
  No notice
• β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects · 2021
  No notice
• Review on the Antibacterial Mechanism of Plant-Derived Compounds against Multidrug-Resistant Bacteria (MDR) · 2021
  No notice
• Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence · 2017
  No notice
• Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa · 2016
  No notice
• Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections · 2015
  No notice
• Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa · 2015
  No notice
• RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition · 2015
  No notice
• Responses of Pseudomonas aeruginosa to antimicrobials · 2014
  No notice
• MexXY multidrug efflux system of Pseudomonas aeruginosa · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.